Guangdong Marubi Biotechnology Co., Ltd. / Fundamentals
Income statement
- Net revenue
€407.91M - Cost of goods sold
€106.94M - Gross profit
€300.97M - SG&A expenses
€220.50M - R&D expenses
€9.44M - EBITDA
€50.07M - D&A
€1.10M - EBIT
€47.86M - Interest expenses
€1.18M - EBT
€47.79M - Tax expenses
€5.47M - Net income
€42.26M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€36.12M - Changes in working capital
€0.00 - Operating cash flow
€43.62M - Capex
€31.68M - Other investing cash flow
€56.28M - Net investing cash flow
€19.65M - Total cash dividends paid
-€61.48M - Issuance of common stock
€0.00 - Debt repayment
€8.10M - Other financing cash flow
€12.93M - Net financing cash flow
-€40.46M - Foreign exchange effects
€37.84K - Net change in cash
€21.99M - Cash at end of period
€151.72M - Free cash flow
€75.30M
Balance sheet
- Cash and cash equivalents
€193.79M - Cash and short-term investments
€240.83M - Total receivables
€12.25M - Inventory
€29.04M - Other current assets
€25.96M - Total current assets
€308.08M - Property, plant & equipment
€141.91M - Goodwill
€0.00 - Intangible assets
€83.13M - Long-term investments
€28.57M - Other non-current assets
€2.01M - Total non-current assets
€265.91M - Total assets
€573.99M - Accounts payable
€44.44M - Short-term debt
€66.00M - Other current liabilities
€43.39M - Total current liabilities
€158.81M - Long-term debt
€50.56K - Deferred tax liabilities
€1.29M - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.94M - Total liabilities
€160.75M - Common stock
€48.30M - Retained earnings
€241.43M - Other equity
€23.98M - Total equity
€413.24M - Total liabilities and shareholders' equity
€573.99M
Company information
- Market capitalization
€2.01B - Employees
1.2K - Enterprise Value
€17.50B
Company ratios
- Gross margin
-
73.8% Much better than peer group: 44.5% - EBITDA margin
-
12.3% Even with peer group: 14.0% - EBIT margin
-
11.7% Even with peer group: 10.4% - EBT margin
-
11.7% Even with peer group: 11.7% - Net margin
-
10.4% Even with peer group: 9.1% - ROE
-
10.2% Even with peer group: 8.8% - ROA
-
7.4% Even with peer group: 6.5% - Asset turnover
-
71.1% Worse than peer group: 79.4% - FCF margin
-
2.9% Even with peer group: 0.3% - FCF yield
0.6% - Efficiency ratio
87.7% - Net sales per employee
-
€344.23K - Net income per employee
-
€35.66K